Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.88 HKD | -0.22% | -2.95% | +26.68% |
Jun. 06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
Jun. 06 | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
Chart calendar The United Laboratories International Holdings Limited
Upcoming events on The United Laboratories International Holdings Limited
Past events on The United Laboratories International Holdings Limited
2024-03-26 | Q4 2023 Earnings Call |
2024-03-25 06:12 pm | Q4 2023 Earnings Release |
2023-09-13 | Ex-dividend day for interim dividend |
2023-08-29 | Q2 2023 Earnings Call |
2023-08-28 | Q2 2023 Earnings Release |
2023-07-03 | Ex-dividend day for extraordinary dividend |
2023-07-03 | Final dividend |
2023-06-22 11:00 pm | Annual General Meeting |
2023-03-21 | Q4 2022 Earnings Release |
2022-09-14 | Ex-dividend day for interim dividend |
2022-08-24 03:00 am | Interim 2022 Earnings Call |
2022-08-23 | Interim 2022 Earnings Release |
2022-07-04 | Ex-dividend day for extraordinary dividend |
2022-07-04 | Ex-dividend day for final dividend |
2022-06-20 11:00 pm | Annual General Meeting |
2022-03-22 | FY 2021 Earnings Call |
2022-03-22 | FY 2021 Earnings Release |
2021-09-15 | Ex-dividend day for interim dividend |
2021-08-25 | Interim 2021 Earnings Release |
2021-07-05 | Ex-dividend day for final dividend |
Past dividends on The United Laboratories International Holdings Limited
2023-09-13 | Interim Payment 0.130739 HKD |
2023-07-03 | Bonus Payment 0.06566 HKD |
2023-07-03 | Final Payment 0.15322 HKD |
2022-09-14 | Interim Payment 0.056736 HKD |
2022-07-04 | Final Payment 0.09341 HKD |
2022-07-04 | Bonus Payment 0.02335 HKD |
2021-09-15 | Interim Payment 0.048273 HKD |
2021-07-05 | Final Payment 0.09663 HKD |
2020-07-06 | Final Payment 0.07665 HKD |
2019-06-16 | Final Payment 0.06827 HKD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million HKD | Released Forecast Spread | 9 167 8 871 3.34% | 10 378 10 835 -4.22% | 11 915 11 824 0.77% | 12 930 12 076 7.08% | 14 892 14 845 0.32% | 16 052 |
EBITDA Million HKD | Released Forecast Spread | 1 964 1 790 9.76% | 1 985 2 246 -11.61% | 2 313 2 728 -15.2% | 3 013 2 709 11.21% | 4 310 3 740 15.25% | 4 270 |
EBIT Million HKD | Released Forecast Spread | 1 244 1 016 22.46% | 1 691 1 469 15.15% | 1 891 1 847 2.41% | 2 180 1 758 23.98% | 3 465 3 012 15.04% | 3 531 |
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 919 831 10.66% | 1 044 1 159 -9.92% | 1 477 1 676 -11.87% | 2 289 1 699 34.75% | 3 625 3 092 17.24% | 3 677 |
Net income Million HKD | Released Forecast Spread | 701 647 8.34% | 832 955 -12.93% | 1 213 1 343 -9.67% | 1 804 1 335 35.12% | 2 928 2 451 19.48% | 2 982 |
EPS HKD | Released Forecast Spread | 0,43 0,37 16.18% | 0,47 0,55 -14.06% | 0,66 0,75 -12.05% | 0,99 0,73 36.13% | 1,61 1,34 19.85% | 1,64 |
Announcement Date | 30/03/20 | 30/03/21 | 23/03/22 | 21/03/23 | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million HKD | Released Forecast Spread | 4 700 4 545 3.41% | 4 826 4 986 -3.21% | 5 286 5 728 -7.73% | 5 669 5 653 0.27% | 6 120 6 024 1.6% | 5 950 5 578 6.67% | 7 018 5 727 22.56% | 7 442 5 895 26.25% | 7 407 7 573 -2.2% | 7 186 | 7 452 | 7 185 | 7 457 |
EBIT Million HKD | Released Forecast Spread | 954 782 22.01% | 825 1 060 -22.23% | 907 741 22.36% | 1 279 649 97.22% | 1 693 861 96.78% | 1 761 1 714 2.76% | 1 577 | 1 545 | 1 425 | 1 154 | |||
EPS HKD | Released Forecast Spread | 0,23 0,19 23.85% | 0,13 0,27 -49.55% | 0,33 0,36 -8.26% | 0,41 0,31 30.37% | 0,24 0,37 -33.98% | 0,40 0,33 22.06% | 0,60 0,31 95.13% | 0,76 0,38 99.92% | 0,85 0,79 6.45% | 0,73 | 0,71 | 0,69 | 0,53 |
Announcement Date | 30/03/20 | 25/08/20 | 30/03/21 | 26/08/21 | 23/03/22 | 23/08/22 | 21/03/23 | 29/08/23 | 27/03/24 | - | - | - | - |
Past sector events for The United Laboratories International Holdings Limited
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 3933 Stock
- Calendar The United Laboratories International Holdings Limited